Sector
Other
About
Adherex Technologies Inc. (TSX:AHX) is a Canadian publicly traded biotechnology corporation. It has a platform technology that includes a promising new way to treat cancer. The lead product, Exherin, targets and destroys the abnormal blood vessels that feed the cancerous tumors, essentially starving the tumor.
Adherex completed its initial public offering in Q2 2001.
Adherex news
<< back
| 
